Development and validation of derivative spectroscopic method for simultaneous estimation of cefixime trihydrate and azithromycin dihydrate in combined dosage form

International Journal of Pharma and Bio Sciences

Volumn 3, Issue 3, 2012, Pages

  Shah, Vishal ^a   Raj, Hasumati ^a  

^a Shree Dhanvantary Pharmacy College   (India)

Author keywords

Azithromycin dihydrate; Cefixime trihydrate; Combined dosage form; Derivative spectroscopy; Zero crossing point

Indexed keywords

AZITHROMYCIN; AZITHROMYCIN PLUS CEFIXIME; CEFIXIME; UNCLASSIFIED DRUG; WATER; ZIMNIC AZ;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG DOSAGE FORM; ECONOMIC EVALUATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SECOND ORDER DERIVATIVE SPECTROSCOPY; SENSITIVITY ANALYSIS; SPECTROSCOPY; VALIDATION PROCESS; ZERO CROSSING POINT;

EID: 84867692820     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ferrara A, Santos CD, Cimbro M: Comparative antimicrobial activity and post-antibiotic effect of azithromycin, clarithromycin and roxithromycin against some respiratory pathogens. International Journal of Antimicrobial Agents, 1996; 7:181-186.
2. Sharma HL, Sharma KK "principles of pharmacology" edition 2008: 761-762
3. Goldman RC, Fesik SW, Doran CC: Role of protonated and neutral forms of macrolides in binding to ribosomes from Grampositive and Gram-negarive bacteria. Antimicrobial Agents Chemotherapy, 1990; 34:426-431.
4. Treadway G, Reisman A: Tolerability of 3-day, once-daily Azithromycin Dihydrate suspension versus standard treatments for community-acquired paediatric infectious diseases. International Journal of Antimicrobial Agents, 2001; 18:427-431.
5. Pacifico L, Chiesa C: Azithromycin Dihydrate in Children: A Critical Review of the Evidence. Current Therapeutic Research, 2002; 63:1:54-76.
6. Treadway G, Pontani D, Reisman A: The safety of Azithromycin Dihydrate in the treatment of adults with communityacquired respiratory tract infections. International Journal of Antimicrobial Agents, 2002; 19:189-194.
7. Ferrara A, Santos C, Cimbro M, Grassi G: Comparative antimicrobial activity and postantibiotic effect of Azithromycin Dihydrate, clarithromycin and roxithromycin against some respiratory pathogens. International Journal of Antimicrobial Agents, 1996; 7:181-186.
8. Hoepelman I, Mollers M, Schied M: A short (3-day) course of Azithromycin Dihydrate tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome. International Journal of Antimicrobial Agents, 1998; 9:141-146.
9. Block S, Arrieta A, Seibel M: Single-Dose (30 mg/kg) Azithromycin Dihydrate Compared with 10-Day Amoxicillin/Clavulanate for the Treatment of Uncomplicated Acute Otitis Media: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Current Therapeutic Research, 2003; 64(A):A30-A42.
10. Rothermel C: Single-Dose Azithromycin Dihydrate for Acute Otitis Media: A Pharmacokinetic/Pharmacodynamic Rationale. Current Therapeutic Research, 2003; 64(A): V.
11. Kabra S, Pawaiya R, Lodha R: Long-term daily high and low doses of Azithromycin Dihydrate in children with cystic fibrosis: A randomized controlled trial. Journal of Cystic Fibrosis, 2010; 9:17-23.
12. Yousef A, Jaffe A: The Role of Azithromycin Dihydrate in Patients with Cystic Fibrosis. Paediatric Respiratory Reviews, 2010; 11:108-114.
13. -1 In Paediatric Patients. Pharmacological Research, 2002; 46:1:95-100.
14. Parnham M: Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term Azithromycin Dihydrate treatment. European Journal of Pharmacology, 2005; 517:132-143.
15. Nakornchai S, Konthiang P: Activity of Azithromycin Dihydrate or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Tropica, 2006; 100:185-191.
16. Ferrera K, Bomasang E: Azithromycin Dihydrate versus First Line Antibiotics in the Therapeutic Management of Documented Cases of Typhoid Fever: A Metaanalysis. Phil Journal Microbiol Infectious Diseases, 2004; 33:4:163-168.
17. Butler T, Sridhar C, Dagac M, Pathak K: Treatment of typhoid fever with Azithromycin Dihydrate versus chloramphenicol in a randomized multicentre trial in India. Journal of Antimicrobial Chemotherapy, 1999; 44:2:243-250.
18. Richard F, Michelle C, Luigi X: Lippincott's Illustrated Reviews: Pharmacology", 4th Edition: 360-364
19. Quintiliuni R: Cefixime Trihydrate in the Treatment of Patients with Lower Respiratory Tract Infections: Results of US Clinical Trials. Clinical Therapeutics, 1996; 18:3:373-390.
20. Ani R: Comparative, Multicenter Studies of Cefixime Trihydrate and Amoxicillin in the Treatment of Respiratory Tract Infections. The American Journal of Medicine, 1988; 85(3A):6-13.
21. Genvresse I, Carbon C: Cefixime Trihydrate. International Journal of Antimicrobial Agents, 1993; 3:1-16.
22. Iravani A, Richard G: A Double-Blind, Multicenter, Comparative Study of the Safety and Efficacy of Cefixime Trihydrate versus Amoxicillin in the Treatment of Acute Urinary Tract Infections in Adult Patients. The American Journal of Medicine, 1988; 85(3A):17-23.
23. Westphal J, Jehl F, Schloegel M, Monteil H, Brogardl J: Biliary Excretion of Cefixime Trihydrate: Assessment in Patients Provided with T-Tube Drainage. Antimicrobial Agents and Chemotherapy, 1993; 37:7:1488-1491.
24. Avner S, Buckley J, Pearlman D, Vitanza J: Comparison of Cefixime Trihydrate qd & Amoxicillin tid for acute Sinusitis. Journal of Allergy and Clinical Immunology, 1991; 87:1:143.
25. Johnson C, Susan A, Dennis M: Cefixime Trihydrate compared with amoxicillin for treatment of acute otitis media. Pediatric Pharmacology and Therapeutics, 1991:117-122.
26. Fera M, Carbone M, Foch A: Activity of Cefixime Trihydrate against Helicobacter pylori. International Journal of Antimicrobial Agents, 1993; 3:105-108.
27. Verhoef J, Gillissen A: Resistant Haemophilus influenzae in communityacquired respiratory tract infections: a role for Cefixime Trihydrate. International Journal of Antimicrobial Agents, 2003; 21:501-509.
28. Furuya R, Nakayama H, Kanayama A: In vitro synergistic effects of double combinations of β-lactams and Azithromycin Dihydrate against clinical isolates of Neisseria gonorrhoeae. Journal of Infection And Chemotherapy, 2006; 12:4:172-176.
29. Rahman M, Hoque M, Mamun S, Rahman Z, Sultan Z: Comparison of Single-dose Oral Azithromycin Dihydrate with Azithromycin Dihydrate and Cefixime Trihydrate for treatment of uncomplicated gonococcal urethritis. International Conference on AIDS, 2004:11-16.
30. Ryan K: The phs Gene and Hydrogen Sulfide Production by Salmonella typhimurium. Journal of Bacteriology, 1987; 169:6:2391-2397.
31. AHFS Drug information. 2009:139-140.
32. Kucer's use of Antibiotics, 8th edition: 400,804
33. Indian Pharmacopoeia Govrnment of India, Ministry of Health & Welfare, 6th edition 2010; 2:857-858
34. Indian Pharmacopoeia Govrnment of India, Ministry of Health & Welfare, 6th edition 2010; 2:1012-1013
35. Zubata P, Ceresole R, Rosasco R, Pizzorno M: A new HPLC method for Azithromycin Dihydrate quantitation. Journal of Pharmaceutical and Biomedical Analysis, 2002; 27:833-836.
36. Shaikh K, Patil S, Devkhile A: Development and validation of a reversed-phase HPLC method for simultaneous estimation of ambroxol hydrochloride and Azithromycin Dihydrate in tablet dosage form. Journal of Pharmaceutical and Biomedical Analysis, 2008; 48:1481-1484.
37. Singh S, Prakash D, Mani T: Development and Validation of Stability indicating RPHPLC Method for the estimation of Azithromycin Dihydrate Suspension. International Journal of ChemTech Research, 2010; 2:4:1939-1944.
38. Shena Y, Yina C, Sub M, Tua J: Rapid, sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantification of topically applied Azithromycin Dihydrate in rabbit conjunctiva tissues. Journal of Pharmaceutical and Biomedical Analysis, 2010; 52:99-104.
39. Kulikov A, Verushkin A: Development and Validation of a Micellar Liquid Chromatographic Method with UV Detection for Determination of Azithromycin Dihydrate in Tablets and Capsules. Chromatographia, 2004; 60:1-2:33-38.
40. Sultana N, Arayne M, Hussain F, Fatima A: Degradation studies of Azithromycin Dihydrate And its Spectrophotometric determination in Pharmaceutical Dosage form. Pakistan Journal of Pharmaceutical Science, 2006; 19:2:94-98.
41. Suhagia B, Shah S, Rathod I, Patel H, Doshi K: Determination of Azithromycin Dihydrate in pharmaceutical dosage forms by Spectrophotometric method. Indian Journal of Pharmaceutical sciences, 2006; 68:2:242-245.
42. Patel C, Chaudahri C, Patel S, Patel N: Visible spectrophotometric method for estimation of Azithromycin Dihydrate from tablet formulation
43. Yanamandra R, Chaudhary A, Rao S, Patro B: UPLC Method for Simultaneous Separation and Estimation of Secnidazole, Fluconazole and Azithromycin Dihydrate in Pharmaceutical Dosage Forms. E-Journal of Chemistry, 2010; 7:S1:S363-S371.
44. Sharma R, Pathodiya G, Mishra G, Sharma M: Simultaneous Estimation and Validation of Cefixime Trihydrate Trihydrate and Ornidazole in Bulk and Tablets using Hydrotropic Solubilizing Agents. Journal of Pharmacy Research, 2010; 3:12:2953-2955.
45. Dhoka M, Gawande V, Joshi P, Gandhi S, Patil N: Simultaneous estimation of Cefixime Trihydrate and Erdosteine in capsule dosage form by spectrophotometric method. Hindustan Antibiot Bulletin, 2009; 51:1-4:29-32.
46. Rajendran S, Santhi N, Kumar P, Solomon S, Narayanan V: Simultaneous Estimation of Cefixime Trihydrate and Ofloxacin in Bulk and Tablet Dosage Form. Asian Journal Pharmaceutical Analysis, 2011; 1:2:36-38.
47. Gandhi S, Rajput S: Study of Degradation Profile and Development of Stability Indicating Methods for Cefixime Trihydrate. Indian journal of Pharmaceutical sciences, 2009; 71:4:438-442.
48. Deshpande M, Kasture V, Gosavi S: Application of HPLC and HPTLC for the Simultaneous Determination of Cefixime Trihydrate Trihydrate and Ambroxol Hydrochloride in Pharmaceutical Dosage Form. Eurasian Journal Analytical Chemistry, 2010; 5:3:227-238.
49. Nemutlu E, Ki{dotless}r S, Katlan D, Beksac M: Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, Cefixime Trihydrate and cefoperazone. Talanta, 2009; 80:117-126.
50. Meng F, Chen X, Zeng Y, Zhong D: Sensitive liquid chromatography-tandem mass spectrometry method for the determination of Cefixime Trihydrate in human plasma: Application to a pharmacokinetic study. Journal of Chromatography B, 2005; 819:277-282.
51. Khan A, Iqbal Z, Khan M, Javed K, Khan A, Ahmad L, Shah Y, Nasir F: Simultaneous determination of cefdinir and Cefixime Trihydrate in human plasma by RPHPLC/ UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study. Journal of Chromatography B, 2011; 879:2423-2429.
52. Falkowski A, Look Z, Noguchi H, Silber M: Determination of Cefixime Trihydrate in biological samples by Reversed-Phase High-Performance Liquid Chromatography. Journal of Chromatography, 1987; 422:145-152.
53. Eric S, Agbaba D, Zivanov D, Vladimirov S: HPTLC determination of ceftriaxone, Cefixime Trihydrate and cefotaxime in dosage forms. Journal of Pharmaceutical and Biomedical Analysis, 1998; 18:893-898.
54. Jain R, Gupta V, Jadon N, Radhapyari K: Voltammetric determination of Cefixime Trihydrate in pharmaceuticals and biological fluids. Analytical Biochemistry, 2010; 407:79-88.
55. Reddy T, Sreedhar M, Reddy S: Voltammetric behavior of Cefixime Trihydrate and Cefpodoxime Proxetil and determination in pharmaceutical formulations and urine. Journal of Pharmaceutical and Biomedical Analysis, 2003; 31:811-818.
56. Honda S, Taga A, Kakehi K, Koda S, Okamoto Y: Determination of celfixime and its metabolites by high Performance capillary electrophoresis. Journal of Chromatography, 1992; 590:364-368.